The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes for phase II study of durvalumab (D) and tremelimumab (T) plus PET-directed chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma (EA).
 
Joan Choo
No Relationships to Disclose
 
Abraham Wu
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Simphotek
Consulting or Advisory Role - MORE Health
 
Steven Maron
Stock and Other Ownership Interests - OneCell Diagnostics India
Honoraria - American Physician CME; Clarion Healthcare; Clinical Care Options; Medpage; MJH Healthcare Holdings, LLC; Oncoview; Physicans' Education Resource; Practicing Clinician Exchange; Vindico Medical Education
Consulting or Advisory Role - Amgen; Elevation Oncology; Everest Medicine; Everest Medicine; Everest Medicine; Pinetree Therapeutics; Purple Biotech
Research Funding - AstraZeneca (Inst); Guardant Health (Inst); PAIGE.AI (Inst)
 
Smita Joshi
Travel, Accommodations, Expenses - DAVA Oncology
 
David Ilson
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Lilly/ImClone; Merck; Oncolys BioPharma; Roche/Genentech; Taiho Pharmaceutical
 
Yelena Janjigian
Stock and Other Ownership Interests - Inspirna; OncoDaily; Veda Life Sciences
Honoraria - Abbvie; AmerisourceBergen; Arcus Biosciences; AskGene Pharma; Astellas Pharma; AstraZeneca; Basilea Pharmaceutical; Bayer; BeOne; Boehringer Ingelheim; Bristol-Myers Squibb; Clinical Care Options; Daiichi Sankyo; eChinaHealth; Ed Med Resources (OncInfo); Eisai; Geneos; Genzyme; Gilead Sciences; GlaxoSmithKline; Guardant Health; H.C. Wainwright & Co.; HMP Education; i3 Health; i3 Health; IDEOlogy Health; Imedex; Imugene; Inspirna; Lilly; Lynx Health; Master Clinician Alliance; Merck; Merck Serono; Mersana; Michael J. Hennessy Associates; Paradigm; Peerview; Pfizer; Physicians' Education Resource, LLC; Regeneron; Research to Practice; Seagen; Silverback Therapeutics; Suzhou Liangyihui Network Technology; Talem Health; TotalCME; WebMD; Zymeworks
Consulting or Advisory Role - Abbvie; AmerisourceBergen; Arcus Biosciences; AskGene Pharma; Astellas Pharma; AstraZeneca; Basilea Pharmaceutical; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Clinical Care Options; Daiichi Sankyo; Debbies Dream Foundation; Ed Med Resources (OncLive); Eisai; Geneos; Genzyme; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; H.C. Wainwright & Co.; HMP Education; Imedex; Imugene; Inspirna; Jazz Pharmaceuticals; Lilly; Lynx Health; Merck; Merck Serono; Mersana; Michael J. Hennessy Associates; OncoDaily; Paradigm; Peerview; Pfizer; Physicians' Education Resource, LLC; Research to Practice; Seagen; Signatera; Silverback Therapeutics; WebMD; Zymeworks
Research Funding - Arcus Biosciences (Inst); Astellas Pharma; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cycle for Survival (Inst); Department of Defense (Inst); Fred's Team (Inst); Genentech/Roche (Inst); Inspirna (Inst); Lilly (Inst); Merck (Inst); NCI (Inst); Stand up to Cancer (Inst); Transcenta (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb Japan; Merck
Other Relationship - Axis Medical Education; Clinical Care Options; Giants of Cancer Care; Research to Practice
 
Marina Shcherba
No Relationships to Disclose
 
Jia Li
No Relationships to Disclose
 
Laura Tang
Honoraria - Astellas Scientific and Medical Affairs Inc
 
Smita Sihag
Honoraria - Intuitive Surgical
Consulting or Advisory Role - AstraZeneca
Research Funding - Delfi Diagnostics
Travel, Accommodations, Expenses - Medtronic
 
Bernard Park
Stock and Other Ownership Interests - CEEVRA
Honoraria - Intuitive Surgical; Medtronic
Travel, Accommodations, Expenses - Intuitive Surgical
 
David Jones
Consulting or Advisory Role - AstraZeneca; Merck; More Health
Speakers' Bureau - DAVA Oncology; Genentech/Roche
Research Funding - Merck (Inst)
Expert Testimony - MGH Hospitals
Travel, Accommodations, Expenses - DAVA Oncology
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Merck
 
Daniela Molena
Honoraria - AstraZeneca; AstraZeneca; Intuitive Surgical; Johnson & Johnson/MedTech; Medela; Merck
Consulting or Advisory Role - AstraZeneca; AstraZeneca/MedImmune; Johnson & Johnson; proteomics; proteomics
Travel, Accommodations, Expenses - AstraZeneca
 
Geoffrey Ku
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca/Daiichi Sankyo; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; I-Mab; Jazz Pharmaceuticals; Merck Sharp & Dohme; Oncolys BioPharma
Research Funding - Adaptimmune (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CARsgen Therapeutics (Inst); Daiichi Sankyo (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Oncolys BioPharma (Inst); Pieris Pharmaceuticals (Inst); Triumvira Immunologics, Inc (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; ImaBiotech; Merck Sharp & Dohme; Pieris Pharmaceuticals